rawfin.tv
Retension Pharmaceuticals Prices IPO at $12 Per Share
MarketsstocksAI Generated

Retension Pharmaceuticals Prices IPO at $12 Per Share

By rawfin.tv Markets Desk||Updated |1 min read|AI-assisted · Methodology

Retension Pharmaceuticals has announced the pricing of its initial public offering at $12 per share. The company is set to begin trading on the Nasdaq exchange.

IPOPharmaceuticalsStock MarketNew Listings

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks